# Elanco Animal Health Inc: filings

ELAN · NYSE · CIK 1739104 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/elan.md) · [Financials](/companies/elan/financials.md) · [Filings](/companies/elan/filings.md) · [Insiders](/companies/elan/insiders.md)

## Reports and events: 168 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 662, 8-K 116, 3 42, SC 13G/A 30, 10-Q 24, SC 13G 12, DEFA14A 9, 10-K 8, CORRESP 8, DEF 14A 8, DFAN14A 8, SCHEDULE 13G/A 8, UPLOAD 7, SD 6, 425 5, SC 13D/A 5, SCHEDULE 13G 5, 424B5 4, 5 4, EFFECT 4, S-8 4, 424B3 3, S-4 3, 144 2, 424B7 2, 8-A12B 2, 8-K/A 2, CERT 2, FWP 2, PRE 14A 2, S-1/A 2, S-4/A 2, SC 13D 2, 25-NSE 1, 424B4 1, DRS 1, DRS/A 1, DRSLTR 1, S-1 1, S-3ASR 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-08-05 | 13:06 ET | [10-Q](/filings/0001739104-26-000043.md) | Quarterly report, period 2026-06-30 | 0001739104-26-000043 |
| 2026-08-05 | 10:27 ET | [8-K](/filings/0001739104-26-000040.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001739104-26-000040 |
| 2026-05-27 | 21:00 ET | [8-K](/filings/0001104659-26-067002.md) | 5.07 Shareholder vote results | 0001104659-26-067002 |
| 2026-05-06 | 13:04 ET | [10-Q](/filings/0001739104-26-000030.md) | Quarterly report, period 2026-03-31 | 0001739104-26-000030 |
| 2026-05-06 | 10:30 ET | [8-K](/filings/0001739104-26-000027.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001739104-26-000027 |
| 2026-04-08 | 14:07 ET | [DEF 14A](/filings/0001739104-26-000016.md) | Proxy statement, period 2025-12-31 | 0001739104-26-000016 |
| 2026-02-24 | 14:19 ET | [10-K](/filings/0001739104-26-000012.md) | Annual report, period 2025-12-31 | 0001739104-26-000012 |
| 2026-02-24 | 11:28 ET | [8-K](/filings/0001739104-26-000008.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001739104-26-000008 |
| 2026-01-12 | 13:00 ET | [8-K](/filings/0001104659-26-002723.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-002723 |
| 2025-12-09 | 12:45 ET | [8-K](/filings/0001104659-25-119486.md) | 2.05 Exit or disposal costs; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-119486 |
| 2025-11-05 | 14:06 ET | [10-Q](/filings/0001739104-25-000071.md) | Quarterly report, period 2025-09-30 | 0001739104-25-000071 |
| 2025-11-05 | 11:30 ET | [8-K](/filings/0001739104-25-000068.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001739104-25-000068 |
| 2025-11-03 | 12:30 ET | [8-K](/filings/0001104659-25-105246.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001104659-25-105246 |
| 2025-08-07 | 13:05 ET | [10-Q](/filings/0001739104-25-000055.md) | Quarterly report, period 2025-06-30 | 0001739104-25-000055 |
| 2025-08-07 | 10:27 ET | [8-K](/filings/0001739104-25-000052.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001739104-25-000052 |
| 2025-06-26 | 20:01 ET | [8-K](/filings/0001104659-25-063027.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001104659-25-063027 |
| 2025-05-28 | 11:30 ET | [8-K](/filings/0001104659-25-053305.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-053305 |
| 2025-05-21 | 22:42 ET | [8-K](/filings/0001104659-25-051136.md) | 5.07 Shareholder vote results | 0001104659-25-051136 |
| 2025-05-07 | 13:05 ET | [10-Q](/filings/0001739104-25-000042.md) | Quarterly report, period 2025-03-31 | 0001739104-25-000042 |
| 2025-05-07 | 10:30 ET | [8-K](/filings/0001739104-25-000040.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001739104-25-000040 |
| 2025-03-27 | 16:21 ET | [DEF 14A](/filings/0001739104-25-000030.md) | Proxy statement, period 2025-05-16 | 0001739104-25-000030 |
| 2025-03-17 | 20:20 ET | [8-K](/filings/0001104659-25-024432.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-024432 |
| 2025-02-25 | 14:12 ET | [10-K](/filings/0001739104-25-000014.md) | Annual report, period 2024-12-31 | 0001739104-25-000014 |
| 2025-02-25 | 12:05 ET | [8-K](/filings/0001739104-25-000011.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001739104-25-000011 |
| 2025-01-13 | 13:31 ET | [8-K](/filings/0001104659-25-002881.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-002881 |
| 2024-11-12 | 22:28 ET | [8-K](/filings/0001104659-24-116942.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-24-116942 |
| 2024-11-07 | 14:07 ET | [10-Q](/filings/0001739104-24-000039.md) | Quarterly report, period 2024-09-30 | 0001739104-24-000039 |
| 2024-11-07 | 11:27 ET | [8-K](/filings/0001739104-24-000036.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001739104-24-000036 |
| 2024-10-16 | 10:30 ET | [8-K](/filings/0001104659-24-108914.md) | 7.01 Regulation FD disclosure | 0001104659-24-108914 |
| 2024-08-13 | 20:32 ET | [8-K](/filings/0001104659-24-089000.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001104659-24-089000 |
| 2024-08-08 | 13:10 ET | [10-Q](/filings/0001739104-24-000027.md) | Quarterly report, period 2024-06-30 | 0001739104-24-000027 |
| 2024-08-08 | 10:29 ET | [8-K](/filings/0001739104-24-000025.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001739104-24-000025 |
| 2024-07-09 | 12:30 ET | [8-K](/filings/0001104659-24-078464.md) | 2.01 Completion of an acquisition or disposition; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-24-078464 |
| 2024-07-03 | 21:23 ET | [8-K](/filings/0001104659-24-077840.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001104659-24-077840 |
| 2024-06-04 | 20:16 ET | [8-K](/filings/0001104659-24-068253.md) | 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001104659-24-068253 |
| 2024-05-08 | 13:06 ET | [10-Q](/filings/0001739104-24-000018.md) | Quarterly report, period 2024-03-31 | 0001739104-24-000018 |
| 2024-05-08 | 10:28 ET | [8-K](/filings/0001739104-24-000016.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001739104-24-000016 |
| 2024-04-19 | 12:00 ET | [DEF 14A](/filings/0001140361-24-020680.md) | Proxy statement, period 2024-05-30 | 0001140361-24-020680 |
| 2024-04-01 | 12:25 ET | [8-K](/filings/0001104659-24-041558.md) | 1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-24-041558 |
| 2024-02-26 | 14:05 ET | [10-K](/filings/0001739104-24-000009.md) | Annual report, period 2023-12-31 | 0001739104-24-000009 |
| 2024-02-26 | 11:30 ET | [8-K](/filings/0001739104-24-000004.md) | 2.02 Results of operations; 2.05 Exit or disposal costs; 9.01 Financial statements and exhibits | 0001739104-24-000004 |
| 2024-02-05 | 11:40 ET | [8-K](/filings/0001104659-24-010337.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-24-010337 |
| 2024-01-08 | 22:00 ET | [8-K](/filings/0001104659-24-002283.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-24-002283 |
| 2024-01-02 | 14:07 ET | [8-K](/filings/0001104659-24-000140.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-24-000140 |
| 2023-11-07 | 21:14 ET | [10-Q](/filings/0001739104-23-000023.md) | Quarterly report, period 2023-09-30 | 0001739104-23-000023 |
| 2023-11-07 | 11:29 ET | [8-K](/filings/0001739104-23-000021.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001739104-23-000021 |
| 2023-10-04 | 11:30 ET | [8-K](/filings/0001104659-23-106600.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-23-106600 |
| 2023-08-07 | 20:11 ET | [10-Q](/filings/0001739104-23-000013.md) | Quarterly report, period 2023-06-30 | 0001739104-23-000013 |
| 2023-08-07 | 10:30 ET | [8-K](/filings/0001104659-23-088037.md) | 1.01 Entry into a material agreement; 2.02 Results of operations; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001104659-23-088037 |
| 2023-07-13 | 21:27 ET | [8-K](/filings/0001104659-23-080837.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-23-080837 |

Page 1 of 4. [Older](/companies/elan/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:15 ET. No prices; not investment advice.